IL4, interleukin 4, 3565

N. diseases: 996; N. variants: 23
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 Biomarker disease MGD
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 AlteredExpression disease BEFREE In contrast to normal donors T cells from donors with AD predominantly express mRNA for IL-4, IL-5, and only diminished levels for IFN-gamma and IL-12 upon stimulation with SEB and SEA. 7819740 1995
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 AlteredExpression disease BEFREE These data indicate that although acute and chronic AD lesions are associated with increased activation of IL-4 and IL-5 genes, initiation of acute skin inflammation in AD is associated with a predominance of IL-4 expression whereas maintenance of chronic inflammation is predominantly associated with increased IL-5 expression and eosinophil infiltration. 8040343 1994
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 Biomarker disease BEFREE The spontaneous expression of IL-4 mRNA in unstimulated cultures from children with atopic dermatitis supports the possibility that previous in vivo activation has occurred, and suggests that IL-4 production is increased in vivo in atopic dermatitis. 8082305 1994
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 AlteredExpression disease BEFREE Abnormal IL-4 gene expression by atopic dermatitis T lymphocytes is reflected in altered nuclear protein interactions with IL-4 transcriptional regulatory element. 8618052 1996
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 AlteredExpression disease BEFREE Increased levels of IL-13 mRNA, but not IL-4 mRNA, are found in vivo in peripheral blood mononuclear cells (PBMC) of patients with atopic dermatitis (AD). 9158100 1997
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 AlteredExpression disease BEFREE IL-4 mRNA expression was increased in stimulated T cells of children with allergic asthma and atopic dermatitis, but not in those with non-allergic asthma as compared with healthy controls. 9199876 1997
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 Biomarker disease BEFREE To investigate the role of potentially cross-reactive T cells in the pathogenesis of psoriasis, interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) responses of circulating T cells to these peptides were analysed by ELISPOT and RT-PCR in 14 psoriatic patients, 12 healthy individuals and six patients with atopic dermatitis (AD). 9201310 1997
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 Biomarker disease BEFREE IL-4 mRNA was detected in OB and two other AD-derived cell lines by IL-4-specific reverse transcription-polymerase chain reaction.IgE was also produced by the OB cells. 9355960 1997
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 GeneticVariation disease BEFREE Since the T allele was reported to be associated with increased IL4 gene promoter activity compared with the C allele, our data indicate that genetic differences in transcriptional activity of the IL4 gene influence AD predisposition, particularly in Japanese, because of a high frequency of the T allele. 9643293 1998
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 Biomarker disease BEFREE In this study, we investigated the mRNA expression of the IL-4 receptor (IL-4Ralpha), IL-5Ralpha, GM-CSFRalpha, and IL-12Rbeta2 in biopsy specimens from acute and chronic AD lesions, uninvolved AD skin, normal skin, and psoriatic skin lesions. 9723668 1998
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 AlteredExpression disease BEFREE Finally, spontaneous mRNA expression of IL-4 in blood CD8+ CD45RO+ T cells isolated from AD-H patients was increased, as determined by reverse transcriptase-polymerase chain reaction. 9856820 1998
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 Biomarker disease BEFREE Family studies on these infants have shown a link between atopic dermatitis and the genomic region 5q31 adjacent to the interleukin-4 gene cluster. 10480758 1999
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 GeneticVariation disease BEFREE Our approach was to identify polymorphisms within the promoter regions of IL-4 and test their association with atopic eczema. 11496248 2001
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 GeneticVariation disease BEFREE These results suggest that the polymorphisms in the IL-4 gene and the IL-4 receptor alpha chain gene play no role in the development of atopic eczema in patients who have normal IgE productivity. 11678851 2001
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 Biomarker disease BEFREE PBMC and acute skin lesions of patients with atopic dermatitis (AD) are characterized by increased IL-4 and IL-13, but decreased IFN-gamma production. 11751999 2002
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 Biomarker disease CTD_human Azole derivatives, ketoconazole, itraconazole, miconazole, and nonazole terbinafine hydrochloride, and tolnaftate reduced interleukin-4 and interleukin-5 secretion without altering that of interferon-gamma and interleukin-2 in anti-CD3/CD28-stimulated T cells from both atopic dermatitis patients and normal donors. 11886533 2001
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 Biomarker disease BEFREE Anti-mycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis. 11886533 2001
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 AlteredExpression disease BEFREE Together, our present study indicates that AP-1 is over-activated by IL-4 in PBMC of the atopic patients with the higher IgE level, thereby implying that IL-4-induced over-activation of AP-1 might be one of pathogenic factors in atopic dermatitis. 11912010 2002
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 GeneticVariation disease BEFREE To assess whether genetic variants of TXA2 receptor, IL-4 and IL-4R alpha genes relate to the elevation of serum immunoglobulin E levels in patients with atopic dermatitis (AD), we conducted an association study of genetic polymorphisms of TXA2 receptor (795C/T), IL-4 (-589C/T), and IL-4R alpha (Ile50Val) in a Japanese population (n = 789). 11922633 2002
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 Biomarker disease BEFREE This is the first report to demonstrate that canine atopic dermatitis is associated with over-production of IL-4. 11994107 2002
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 GeneticVariation disease BEFREE We report linkage (P < 0.005) to the - 590C/T polymorphism in the promoter of the IL-4 gene for the semiquantitative trait severity score of AD. 12190659 2002
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 Biomarker disease CTD_human Interleukin-4 plus anti-CD40 increased intracellular cAMP by activating cAMP-synthesizing adenylate cyclase in surface IgE- B cells, and the increase was greater in the cells from atopic dermatitis patients than in those from normal donors. 12230500 2002
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 Biomarker disease BEFREE Ketoconazole suppresses interleukin-4 plus anti-CD40-induced IgE class switching in surface IgE negative B cells from patients with atopic dermatitis. 12230500 2002
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.600 GeneticVariation disease BEFREE In addition, the frequency of the interleukin-4Ralpha polymorphism C3223T and the interleukin-4 polymorphism C590T tended to be higher in extrinsic atopic dermatitis than in intrinsic atopic dermatitis. 12406333 2002